Group 1 - The third supervisory board meeting of Hainan Huluwa Pharmaceutical Group Co., Ltd. was held on June 27, 2025, in accordance with relevant laws and regulations [1][2] - The meeting was attended by all three supervisors, and the chairman of the supervisory board presided over the meeting [1][2] - The supervisory board approved the proposal to temporarily use idle raised funds to supplement the company's working capital, which aligns with regulatory requirements and does not affect the normal investment plan of the raised funds [2] Group 2 - The voting results showed unanimous support with 3 votes in favor, 0 abstentions, and 0 votes against [2] - The supervisory board believes that the temporary use of idle funds will enhance the efficiency of fund utilization and is in the best interest of all shareholders [2]
ST葫芦娃: 海南葫芦娃药业集团股份有限公司第三届监事会2025年第二次临时决议公告